Emerson Electric (EMR) Stock Analysis

OW

EMR Equity Research — OVERWEIGHT — July 2026

Rating date

Jul 1, 2026

40 days ago

Desk view

OW

5D move

Awaiting market data

Peer rank

27p

Investment card · EMR

Here is the analysis for EMR (Emerson Electric Co.).

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Low

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • Trend structure is still bullish. EMR's 50-day SMA ($140.62) remains above the 200-day SMA ($137.65), and both are rising. Price has not broken either MA on a closing basis.
  • But momentum has flipped decisively. The RSI dropping from 65 to 45 in nine sessions is a material deterioration. Sub-50 RSI suggests near-term sellers are in control.
  • The June high ($152.88) is a key resistance level. Until EMR can reclaim the $148–$150 zone, the June 18 peak may act as a near-term ceiling.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

EMR Research Note

Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

25 min read

WebserviceX · Agentic Research Desk

EMR Equity Research Note

Published Jul 1, 2026 · Desk view OVERWEIGHT · Generated 2026-07-02T20:29:16Z · Maintained by Walter Vijayakumar · Methodology · Track record

EMR Stock Rating Summary

EMR bias

OVERWEIGHT

Horizon

Short to medium term

EMR key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

EMR catalyst watch

Trend structure is still bullish. EMR's 50-day SMA ($140.62) remains above the 200-day SMA ($137.65), and both are rising. Price has not broken either MA on a closing basis.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Low

How the call aged · 5D

Awaiting market dataPeer 27p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:18.368227+00:00.

5D move

2026-07-01 → awaiting

Outcome

Awaiting market data

5D trend

-1.36%

Vol (20D ann.)

+34.03%

vs SPY: -3.06%

Close 139.52 (USD, vendor closes)

Batch scorecard · 2026-07-01 · EMR

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 120c1ed5

No QC issues recorded.